🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users injecting substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the platform has removed violative material and prohibited related keywords and query recommendations. The organization said it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, filled with images of slimming results, glowing reviews and detailed guides for preparing or injecting at home.

After minutes of entering one group, a seller posted WhatsApp details, where most purchases occur. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Costs

Within these communities, messages show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to potentially serious medical dangers”.